November 8, 2021
Published by Hearing Health Matters
Brandon Sawalich, President and CEO of Starkey, returns to This Week in Hearing to follow-up with Dr. Bob Traynor to discuss the FDA’s latest decision to release the draft OTC hearing aid rule, as well as the new Medicare Hearing Benefit currently under consideration in Congress – part of a much larger spending bill the White House hopes to pass in the coming weeks.
The pair discuss the implications of both the draft OTC rule, as well as the Medicare hearing benefit, on patients, providers and the overall industry.
SOURCE: Hearing Health Matters